Given that MDMX is frequently amplified and/or overexpressed in various types of human cancer (as summarized in Table 1) and plays an essential role in controlling the p53-MDM2/MDMX loop, MDMX has been demonstrated as a promising molecular target for cancer therapy. This evidence concerns the gene MDM4 and cancer.